SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback